Robin Sherrington
Corporate Officer/Principal en XENON PHARMACEUTICALS INC. .
Fortuna: 336 760 $ al 30/04/2024
Perfil
Robin Sherrington currently works at Xenon Pharmaceuticals, Inc., as Executive Vice President-Strategy & Innovation from 2019.
Dr. Sherrington also formerly worked at Pfizer Inc., as Neuroscience Director from 1999 to 2001, Sequana Therapeutics, Inc., as Neuroscience Director from 1996 to 1999, Axys Pharmaceuticals, Inc., as Neuroscience Director from 1996 to 1999, and Parke-Davis & Co. Ltd., as Neuroscientist.
Dr. Sherrington received his undergraduate degree from The University of Reading and doctorate degree from University College London.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 05/04/2024 | 8 398 ( 0.01% ) | 336 760 $ | 30/04/2024 |
Cargos activos de Robin Sherrington
| Empresas | Cargo | Inicio |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/03/2019 |
Antiguos cargos conocidos de Robin Sherrington.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2001 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/1999 |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Corporate Officer/Principal | 01/01/1999 |
Parke-Davis & Co. Ltd.
 Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Corporate Officer/Principal | - |
Formación de Robin Sherrington.
| University College London | Doctorate Degree |
| The University of Reading | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| XENON PHARMACEUTICALS INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Axys Pharmaceuticals, Inc.
Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Health Technology |
- Bolsa de valores
- Insiders
- Robin Sherrington
